What's New in GU? | Prostate Cancer
128 FOLLOWERS
The Genitourinary (GU) Oncology Program at Weill Cornell Medicine is dedicated to providing cutting-edge care for every stage and type of prostate, kidney, bladder and testicular cancer. Read the blog to find articles on prostate cancer.
What's New in GU? | Prostate Cancer
1y ago
The 2023 American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU) brought together members of the cancer care and research community to share new, innovative findings in the study, diagnosis, and treatment of GU malignancies. This year, ASCO GU was held in a hybrid format, taking place live in San Francisco from February 16-18, as well as virtually online.
A number of members of the Weill Cornell Medicine (WCM) Genitourinary (GU) Oncology Program presented or were involved with new research findings shared at the conference, as well as trial-in-progress updates for some ..read more
What's New in GU? | Prostate Cancer
2y ago
Prostate cancer begins when cells in the prostate gland start to grow out of control. These cancerous cells may remain in the prostate or metastasize and spread to other parts of the body such as the bones, lymph nodes, liver, or lungs.
Prostate-specific membrane antigen (PSMA) is a protein found on the surface of prostate cancer cells. PSMA-targeting can be used to locate, identify, or treat cancerous cells in both the prostate as well as cancerous cells that have metastasized in other organs. This targeting can involve attaching a radionuclide, a particle that gives ..read more
What's New in GU? | Prostate Cancer
3y ago
The Annual NYC Prostate Cancer Summit has been taking place virtually this year as a four-part webinar series for prostate cancer patients and loved ones. We are pleased to be able to come together online while the pandemic prevents us from gathering in-person. Each part of the FREE virtual series features different topics and speakers, and offers unprecedented access to some of the field’s foremost experts! We hope you’ll join us for this webinar series.
Advances in therapeutics have led to improvements in both survival and quality of life for men with advanced or metastatic prostate cancer ..read more
What's New in GU? | Prostate Cancer
3y ago
Prostate-specific membrane antigen (PSMA) is a protein concentrated on the surface of prostate cancer cells with limited expression on other locations in the body. As covered previously on the blog, PSMA can be exploited for both imaging and treatment utilizing either large monoclonal antibodies or small molecule targeting agents.
PSMA-targeting entails attaching a radionuclide (a particle that gives off radiation) to an antibody or small molecule designed to recognize and bind to PSMA. Research into PSMA-targeting has led to promising investigational treatments and trans ..read more
What's New in GU? | Prostate Cancer
4y ago
We are proud to report another year of meaningful patient connections, exciting treatment developments and continued leadership in the field of genitourinary (GU) oncology.
Check out our team’s 2019 highlights.
NEW FACES
Panagiotis “Panos” Vlachostergios, MD, PhD, has joined our team to grow GU oncology patient care and research at NewYork-Presbyterian Brooklyn Methodist Hospital. This is a significant step in our plan to bring our world-class expertise directly to patients who live in Brooklyn, minimizing their expenses and travel time to Manhattan.
NEW EVENTS
In addition to our digital ef ..read more
What's New in GU? | Prostate Cancer
4y ago
The Inaugural New York City Prostate Cancer Summit in 2018 granted us the ability to educate and empower nearly 250 prostate cancer patients, loved ones, healthcare professionals and community members with the latest updates in the field. Following the success of last year’s event, Weill Cornell Medicine, NewYork-Presbyterian Hospital, Columbia University Irving Medical Center and Memorial Sloan Kettering Cancer Center are joining forces again to host the 2nd Annual NYC Prostate Cancer Summit on Saturday, September 21, 2019.
The Summit will take place from 8AM – 2PM at the New York Academy of ..read more
What's New in GU? | Prostate Cancer
5y ago
Over 200 prostate cancer patients and loved ones from across the Tri-State Area attended our Inaugural New York City Prostate Cancer Summit last year. The education and advocacy event was a collaboration among Manhattan’s top academic medical institutions: Weill Cornell Medicine, NewYork-Presbyterian Hospital, Columbia University Irving Medical Center and Memorial Sloan Kettering Cancer Center. Local medical experts and national advocacy leaders came together to discuss topics including immunotherapy, screening, coping with anxiety and much more.
In case you missed the Summit, check out the vi ..read more